Suchergebnisse - "Walter-Sack, Ingeborg"

PubPharm (144)

1

Allgemeinmedizin : der Mentor für die Facharztprüfung und für die allgemeinmedizinische ambulante Versorgung

Erschienen: Stuttgart, Georg Thieme Verlag, [2023]

7., überarbeitete und erweiterte Auflage

von Klimm, H. | Peters-Klimm, F. | Comberg, H. | +23

2

Allgemeinmedizin : der Mentor für die Facharztprüfung und für die allgemeinmedizinische ambulante Versorgung

Erschienen: Stuttgart, Thieme, 2023

7., überarbeitete und erweiterte Auflage

von Klimm, H. | Peters-Klimm, F. | Comberg, H. | +23

3

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2019

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +9

4

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

enthalten in: Phytomedicine | 2019

von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +8

5

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

6

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

7

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

8

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

9

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 24 April 2017

von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +9

10

Erratum to : Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

enthalten in: Cancer chemotherapy and pharmacology | 2016

von König, M. | von Hagens, C. | Hoth, S. | +4

ErratumFor: Cancer Chemother Pharmacol. 2016 Feb;77(2):413-27. doi: 10.1007/s00280-016-2960-7. Epub 2016 Jan 21.. - PMID 26793976

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[15]